Circulating Tumor Cells Methods and Protocols
This volume explores various approaches for enrichment, detection, isolation, and molecular profiling of circulating tumor cells (CTCs). Each chapter provides comprehensive descriptions and guidelines on how to perform innovative experiments in CTC resear
- PDF / 9,476,125 Bytes
- 315 Pages / 504.63 x 737.01 pts Page_size
- 56 Downloads / 248 Views
Mark Jesus M. Magbanua John W. Park Editors
Circulating Tumor Cells Methods and Protocols
METHODS
IN
MOLECULAR BIOLOGY
Series Editor John M. Walker School of Life and Medical Sciences University of Hertfordshire Hatfield, Hertfordshire, AL10 9AB, UK
For further volumes: http://www.springer.com/series/7651
Circulating Tumor Cells Methods and Protocols
Edited by
Mark Jesus M. Magbanua Division of Hematology Oncology, Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, CA, USA
John W. Park Division of Hematology Oncology, Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, CA, USA
Editors Mark Jesus M. Magbanua Division of Hematology Oncology Helen Diller Family Comprehensive Cancer Center University of California-San Francisco San Francisco, CA, USA
John W. Park Division of Hematology Oncology Helen Diller Family Comprehensive Cancer Center University of California-San Francisco San Francisco, CA, USA
ISSN 1064-3745 ISSN 1940-6029 (electronic) Methods in Molecular Biology ISBN 978-1-4939-7143-5 ISBN 978-1-4939-7144-2 (eBook) DOI 10.1007/978-1-4939-7144-2 Library of Congress Control Number: 2017947514 © Springer Science+Business Media LLC 2017 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Printed on acid-free paper This Humana Press imprint is published by Springer Nature The registered company is Springer Science+Business Media LLC The registered company address is: 233 Spring Street, New York, NY 10013, U.S.A.
Dedication In memory of Teresita Mendoza Magbanua, and all the women and men we have lost to cancer.
v
Foreword Treatment options for cancer patients are rapidly increasing, especially those targeting specific molecules in cancer cells. For targeted therapies the presence and distribution of the targets on the cancer cells will ne
Data Loading...
